UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Non-invasive brain stimulation for negative symptoms in schizophrenia: An updated systematic review and meta-analysis

Schizophrenia research, 2018-07, Vol.197, p.34-44

2018

Volltextzugriff (PDF)

Psychopharmacological Treatment of Schizophrenia Over Time in 30 908 Inpatients: Data From the AMSP Study

The international journal of neuropsychopharmacology, 2019-09, Vol.22 (9), p.560-573

2019

Volltextzugriff (PDF)

A rapid positive influence of S-ketamine on the anxiety of patients in palliative care: a retrospective pilot study

BMC palliative care, 2020-01, Vol.19 (1), p.1-15, Article 1

2020

Volltextzugriff (PDF)

Prevalence of the metabolic syndrome in unipolar major depression

European archives of psychiatry and clinical neuroscience, 2012-06, Vol.262 (4), p.313-320

2012

Volltextzugriff (PDF)

Repetitive Transcranial Magnetic Stimulation (rTMS) Improves Facial Affect Recognition in Schizophrenia

Brain stimulation, 2014-07, Vol.7 (4), p.559-563

2014

Volltextzugriff (PDF)

Epidemiology, symptoms, and treatment characteristics of hyponatremic psychiatric inpatients

Journal of clinical psychopharmacology, 2013-12, Vol.33 (6), p.799-805

2013

Volltextzugriff (PDF)

Depressive Stimmungslage und Negativsymptome werden verbessert

InFo Neurologie + Psychiatrie, 2017-01, Vol.19 (1), p.13-13

Cordes, Joachim

2017

Volltextzugriff (PDF)

Attitudes towards repetitive transcranial magnetic stimulation among depressive patients and medical students

Srpski arhiv za celokupno lekarstvo, 2020-07, Vol.148 (7-8), p.447-450

2020

Volltextzugriff (PDF)

Akutbehandlung der Schizophrenie

PSYCH up2date, 2016-01, Vol.10 (1), p.15-27

2016

Volltextzugriff (PDF)

Where are patients who have co-occurring mental and physical diseases located?

International journal of social psychiatry, 2015-08, Vol.61 (5), p.456-464

2015

Volltextzugriff (PDF)

Cultural diversity in physical diseases among patients with mental illnesses

Australian and New Zealand journal of psychiatry, 2013-03, Vol.47 (3), p.250-258

2013

Volltextzugriff (PDF)

Kognitive Defizite der Elektrokonvulsionstherapie bei Depressionen: Moderierende Variablen und neuropsychologische Testverfahren

Fortschritte der Neurologie, Psychiatrie, 2018-11, Vol.86 (11), p.690-698

2018

Volltextzugriff (PDF)

Antipsychotische Polypharmazie in der Behandlung von Patientinnen und Patienten mit Schizophrenie am Beispiel von neun psychiatrischen Fachkliniken des Landschaftsverbandes Rheinland

Psychiatrische Praxis, 2021-07, Vol.48 (5), p.250-257

2021

Volltextzugriff (PDF)

Antidepressive Kombinationsbehandlung bei Patienten mit schwerer depressiver Episode: Verordnungspraxis am Beispiel einer klinischen Stichprobe 2012

Psychiatrische Praxis, 2017-07, Vol.44 (5), p.274-278

2017

Volltextzugriff (PDF)

Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial

Schizophrenia bulletin, 2019-03, Vol.45 (2), p.350-359

2019

Volltextzugriff (PDF)

Attitudes Toward Long-Term Medication Use-A Comparison Between Concerned Populations and a Sample From the German General Population: An Example of Real World Evidence

Journal of clinical psychopharmacology, 2019-07, Vol.39 (4), p.357-361

2019

Volltextzugriff (PDF)

Testing a Motor Score Based on PANSS Ratings: A Proxy for Comprehensive Motor Assessment

Schizophrenia bulletin, 2024-09

2024

Volltextzugriff (PDF)

Cognitive Effects of High-Frequency rTMS in Schizophrenia Patients With Predominant Negative Symptoms: Results From a Multicenter Randomized Sham-Controlled Trial

Schizophrenia bulletin, 2016-05, Vol.42 (3), p.608-618

2016

Volltextzugriff (PDF)

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

Neuropsychopharmacology (New York, N.Y.), 2010-11, Vol.35 (12), p.2367-2377

2010

Volltextzugriff (PDF)

Dopamine D2 Receptor Occupancy Estimated From Plasma Concentrations of Four Different Antipsychotics and the Subjective Experience of Physical and Mental Well-Being in Schizophrenia: Results From the Randomized NeSSy Trial

Journal of clinical psychopharmacology, 2019-11, Vol.39 (6), p.550-560

2019

Volltextzugriff (PDF)

Acute Drug-Induced Hepatitis during Aripiprazole Monotherapy: A Case Report

Journal of Pharmacovigilance, 2016, Vol.4 (2)

2016

Volltextzugriff (PDF)

Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine

Schizophrenia research, 2019-06, Vol.208, p.370-376

2019

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Aktive Filter

ThemaAdolescent

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Englisch
(107)
Deutsch
(22)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(74)
Life Sciences & Biomedicine
(66)
Humans
(52)
Psychiatry
(47)
Male
(41)
Adult
(36)
Female
(36)
Schizophrenia
(31)
Middle Aged
(26)
Neurosciences & Neurology
(18)
Biological And Medical Sciences
(16)
Clinical Neurology
(15)
Medical Sciences
(15)
Pharmacology & Pharmacy
(14)
Schizophrenia - Drug Therapy
(13)
Neurosciences
(12)
Antipsychotic Agents - Adverse Effects
(10)
Depression
(10)
Psychology. Psychoanalysis. Psychiatry
(10)
Psychopathology. Psychiatry
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH)

Non-invasive brain stimulation for negative symptoms in schizophrenia: An updated systematic review and meta-analysis

Psychopharmacological Treatment of Schizophrenia Over Time in 30 908 Inpatients: Data From the AMSP Study

A rapid positive influence of S-ketamine on the anxiety of patients in palliative care: a retrospective pilot study

Prevalence of the metabolic syndrome in unipolar major depression

Repetitive Transcranial Magnetic Stimulation (rTMS) Improves Facial Affect Recognition in Schizophrenia

Epidemiology, symptoms, and treatment characteristics of hyponatremic psychiatric inpatients

Depressive Stimmungslage und Negativsymptome werden verbessert

Attitudes towards repetitive transcranial magnetic stimulation among depressive patients and medical students

Akutbehandlung der Schizophrenie

Where are patients who have co-occurring mental and physical diseases located?

Cultural diversity in physical diseases among patients with mental illnesses

Kognitive Defizite der Elektrokonvulsionstherapie bei Depressionen: Moderierende Variablen und neuropsychologische Testverfahren

Antipsychotische Polypharmazie in der Behandlung von Patientinnen und Patienten mit Schizophrenie am Beispiel von neun psychiatrischen Fachkliniken des Landschaftsverbandes Rheinland

Antidepressive Kombinationsbehandlung bei Patienten mit schwerer depressiver Episode: Verordnungspraxis am Beispiel einer klinischen Stichprobe 2012

Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial

Attitudes Toward Long-Term Medication Use-A Comparison Between Concerned Populations and a Sample From the German General Population: An Example of Real World Evidence

Testing a Motor Score Based on PANSS Ratings: A Proxy for Comprehensive Motor Assessment

Identifying differential predictors for treatment response to amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia: Results of the COMBINE-study

Predicting Response to Repetitive Transcranial Magnetic Stimulation in Patients With Schizophrenia Using Structural Magnetic Resonance Imaging: A Multisite Machine Learning Analysis

Cognitive Effects of High-Frequency rTMS in Schizophrenia Patients With Predominant Negative Symptoms: Results From a Multicenter Randomized Sham-Controlled Trial

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

Dopamine D2 Receptor Occupancy Estimated From Plasma Concentrations of Four Different Antipsychotics and the Subjective Experience of Physical and Mental Well-Being in Schizophrenia: Results From the Randomized NeSSy Trial

Acute Drug-Induced Hepatitis during Aripiprazole Monotherapy: A Case Report

Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine

Aktive Filter

Suchergebnisse filtern